UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Esophageal carcinoma advances in treatment results for locally advanced disease: review

Annals of oncology, 2012-05, Vol.23 (5), p.1095-1103

2012

Volltextzugriff (PDF)

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

BMC cancer, 2017-02, Vol.17 (1), p.141-141, Article 141

2017

Volltextzugriff (PDF)

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

Annals of oncology, 2019-02, Vol.30 (2), p.281-289

2019

Volltextzugriff (PDF)

MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML

Leukemia, 2012-03, Vol.26 (3), p.443-450

2012

Volltextzugriff (PDF)

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy

British journal of cancer, 2011-12, Vol.105 (12), p.1920-1926

2011

Volltextzugriff (PDF)

Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii143

2018

Volltextzugriff (PDF)

Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine

Transplantation, 2000-08, Vol.70 (3), p.447-455

2000

Volltextzugriff (PDF)

Phase I/II study of a novel MDM-2 inhibitor (APG-115) in TP53 wild type salivary gland cancers

European journal of cancer (1990), 2022-10, Vol.174, p.S79-S80

2022

Volltextzugriff (PDF)

Novel Autoantibodies Biomarkers Panel to Prognosticate the Clinical Outcomes in Advanced-stage NSCLC Patients Receiving Anti PD-1/PD-L1 Immunotherapy

American journal of clinical pathology, 2020-10, Vol.154 (Supplement_1), p.S142-S142

2020

Volltextzugriff (PDF)

Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine

Transplantation, 2000-08, Vol.70 (3), p.456-464

2000

Volltextzugriff (PDF)

Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.369-374

1994

Volltextzugriff (PDF)

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1540-1550

2016

Volltextzugriff (PDF)

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function

The Journal of immunology (1950), 1986-07, Vol.137 (2), p.727-732

1986

Volltextzugriff (PDF)

Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model

Transplantation, 2002-01, Vol.73 (1), p.115-121

2002

Volltextzugriff (PDF)

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice

The Journal of immunology (1950), 1986-04, Vol.136 (8), p.2747-2754

1986

Volltextzugriff (PDF)

1137PIntegrated data review evaluating safety, pharmacokinetics (PK) and immunogenicity of RM-1929 photoimmunotherapy (PIT) in subjects with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract

Transplantation, 2002-08, Vol.74 (4), p.445-457

2002

Volltextzugriff (PDF)

436PPreliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion

Transplantation, 2000-11, Vol.70 (10), p.1442-1447

2000

Volltextzugriff (PDF)

CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study

Value in health, 2022-07, Vol.25 (7), p.S333

2022

Volltextzugriff (PDF)

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

JTO clinical and research reports, 2022-08, Vol.3 (8), p.100335-100335, Article 100335

2022

Volltextzugriff (PDF)

Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18047-e18047

2011

Volltextzugriff (PDF)

Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone

Transplantation, 1992-11, Vol.54 (5), p.813-820

1992

Volltextzugriff (PDF)

Suppression of graft-versus-host disease by succinyl acetone in a rat allogeneic bone marrow transplantation model

Transplantation, 1993-02, Vol.55 (2), p.367

1993

Volltextzugriff (PDF)

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

Annals of oncology, 2019-02, Vol.30 (2), p.281

2019

Volltextzugriff (PDF)

1 – 25 von 1.261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.033)
Mit Volltextzugriff
(931)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(804)
Life Sciences & Biomedicine
(611)
Humans
(519)
Female
(317)
Male
(310)
Biological And Medical Sciences
(291)
Medical Sciences
(267)
Animals
(239)
Mice
(196)
Adult
(177)
Oncology
(158)
Physical Sciences
(155)
Middle Aged
(146)
Physics
(145)
Technology
(139)
Materials Science
(104)
Physics, Applied
(103)
Materials Science, Multidisciplinary
(93)
Aged
(89)
Immunology
(84)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Esophageal carcinoma advances in treatment results for locally advanced disease: review

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy

Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine

Phase I/II study of a novel MDM-2 inhibitor (APG-115) in TP53 wild type salivary gland cancers

Novel Autoantibodies Biomarkers Panel to Prognosticate the Clinical Outcomes in Advanced-stage NSCLC Patients Receiving Anti PD-1/PD-L1 Immunotherapy

Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine

Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function

Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice

1137PIntegrated data review evaluating safety, pharmacokinetics (PK) and immunogenicity of RM-1929 photoimmunotherapy (PIT) in subjects with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC)

Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract

436PPreliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion

CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone

Suppression of graft-versus-host disease by succinyl acetone in a rat allogeneic bone marrow transplantation model

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

Suchergebnisse filtern